鹿得医疗(832278) - 2022 Q1 - 季度财报

Financial Performance - Operating revenue for the first quarter of 2022 was CNY 76,264,998.06, down 14.21% year-on-year[17] - Net profit attributable to shareholders for the first quarter of 2022 was CNY 8,290,521.47, a decline of 38.48% compared to the same period last year[17] - The decline in net profit was primarily attributed to the impact of recurring domestic and international pandemic conditions affecting order shipments[18] - Basic earnings per share for the first quarter of 2022 were CNY 0.05, down 58.33% from CNY 0.12 in the same period last year[17] - Total operating revenue for Q1 2022 was ¥76,264,998.06, a decrease of 14.3% compared to ¥88,901,410.56 in Q1 2021[45] - Net profit for Q1 2022 was ¥7,695,420.23, a decline of 42.3% from ¥13,476,472.89 in Q1 2021[48] - The net profit for Q1 2022 was CNY 3,642,258.77, a decrease of 47.5% compared to CNY 6,923,973.83 in Q1 2021[52] - The total profit before tax was CNY 4,201,368.86, down from CNY 7,977,252.24 in Q1 2021, representing a decline of 47.3%[52] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 107.91% year-on-year, amounting to CNY -27,166,252.58[17] - Cash flow from operating activities showed a negative trend, with a net cash outflow indicating potential operational challenges[58] - The cash inflow from sales of goods and services was CNY 82,659,652.38, an increase from CNY 79,855,546.98 in Q1 2021, reflecting a growth of 3.5%[54] - The cash flow from operating activities showed a net outflow of CNY 27,166,252.58, compared to a smaller outflow of CNY 13,066,138.99 in Q1 2021[54] - The ending cash and cash equivalents balance was $166.2 million, down from $124.7 million year-over-year, indicating a decrease in liquidity[58] - The net increase in cash and cash equivalents was -$22.8 million, contrasting with a positive increase of $22.3 million in the previous period[58] - The company recorded interest income of CNY -551,877.52, which reflects a significant increase in interest expenses compared to CNY -208,462.37 in the previous year[52] Assets and Liabilities - Total assets as of March 31, 2022, were CNY 466,045,138.52, a decrease of 3.54% compared to the end of the previous year[17] - The company's total liabilities decreased to 95,452,885.92 yuan from 120,322,340.34 yuan, reflecting a reduction of approximately 20.7%[38] - The company's equity attributable to shareholders increased to 370,650,110.38 yuan from 362,683,642.86 yuan, showing a growth of about 2.7%[38] - Total assets decreased to ¥423,620,991.23 in 2022 from ¥455,833,689.79 in 2021, indicating a reduction in asset base[43] - Total liabilities decreased to ¥73,371,851.35 in 2022 from ¥110,852,710.56 in 2021, showing improved financial leverage[43] Shareholder Information - The total registered capital of the company is CNY 176,000,000[15] - The company reported a total shareholding of 126,618,500 shares, representing 71.95% of the total shares outstanding[26] - Major shareholders include Xiang Youliang with 22.23%, Shanghai Lude Industrial Development Co., Ltd. with 22.13%, and Xiang Guoqiang with 5.82%[26] - The company has a total of 39,130,000 shares held by Xiang Youliang, which is unchanged from the previous period[26] - The company has a total of 10,238,400 shares held by both Xiang Guoqiang and Zhu Zengkai, each representing 5.82%[26] - The company reported a decrease of 2,000 shares held by shareholder Tan Wei Ying, bringing her total to 3,321,200 shares[26] Operational Challenges - The company experienced a rise in raw material procurement costs, leading to increased sales costs and a decline in gross profit margin[19] - The company reported a loss of 1,307,559.96 yuan due to a fire caused by a battery leak, with an additional 50,000.00 yuan paid for assessment fees[31] - The company has ongoing litigation with Sunshine Property Insurance Co., seeking compensation of 1,357,559.96 yuan for the fire incident[31] - The company has no significant assets under seizure, freezing, or mortgage during the reporting period[29] - There were no significant lawsuits or arbitration matters reported during the period[30] Compliance and Governance - The company has maintained compliance with internal review procedures for related party transactions[29] - The company disclosed no profit distribution or capital reserve transfer during the reporting period[33] - The company has no external guarantees or loans provided during the reporting period[29] - The company has conducted share buybacks, with announcements made in 2022[29]